Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Beigene Ltd (BGNE)  
$155.08 1.27 (0.83%) as of 4:30 Wed 3/27


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 90,630,000
Market Cap: 14.05(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $141.8 - $266.78
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  664
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BeiGene is a commercial-stage biotechnology company focused on developing and commercializing molecularly-targeted and immuno-oncology cancer therapeutics. Co.'s clinical-stage drug candidates include: Zanubrutinib, which is a small molecule inhibitor of Bruton's tyrosine kinase for the treatment of mantle cell lymphoma in adult patients; Tislelizumab, which is a humanized monoclonal antibody against the immune checkpoint receptor programmed cell death protein 1; Pamiparib (BGB-290), which is for the treatment of various solid tumors; and Lifirafenib, which is an investigational small molecule inhibitor with RAF monomer and dimer inhibition activities.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 50,397 1,150,397 5,321,251 5,538,274
Total Sell Value $8,434,348 $206,984,348 $1,034,082,993 $1,078,419,805
Total People Sold 2 3 8 9
Total Sell Transactions 3 4 18 51
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 241
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Oyler John Chief Executive Officer   •       •      –    2021-09-15 4 AS $374.39 $9,864,173 D/D (26,158) 0 -40%     
   Oyler John Chief Executive Officer   •       •      –    2021-09-15 4 AS $29.31 $5,575,287 D/D (190,203) 1,736,904 -40%     
   Oyler John Chief Executive Officer   •       •      –    2021-09-14 4 AS $361.56 $13,901,782 D/D (37,877) 0 -37%     
   Oyler John Chief Executive Officer   •       •      –    2021-09-14 4 AS $28.22 $4,447,078 D/D (157,600) 2,267,161 -37%     
   Huang Jane CMO, Hematology   •       –      –    2021-09-13 4 AS $355.37 $4,620,390 D/D (12,901) 0 -32%     
   Amgen Inc 10% Owner   –       –       •   2021-09-10 4 B $302.06 $49,999,938 D/D 165,529 18,943,802 2.45 -29%     
   Huang Jane CMO, Hematology   •       –      –    2021-09-02 4 S $327.18 $178,314 D/D (545) 0 29%     
   Oyler John Chief Executive Officer   •       •      –    2021-09-02 4 AS $324.50 $8,040,809 D/D (24,499) 0 -29%     
   Huang Jane CMO, Hematology   •       –      –    2021-09-01 4 A $0.00 $0 D/D 545 545     -
   Huang Jane CMO, Hematology   •       –      –    2021-09-01 4 S $310.53 $168,307 D/D (542) 0 24%     
   Huang Jane CMO, Hematology   •       –      –    2021-09-01 4 A $0.00 $0 D/D 7,124 312,948     -
   Oyler John Chief Executive Officer   •       •      –    2021-09-01 4 AS $324.41 $8,306,484 D/D (25,501) 0 -24%     
   Oyler John Chief Executive Officer   •       •      –    2021-09-01 4 AS $24.34 $3,105,165 D/D (127,558) 2,917,162 -24%     
   Huang Jane CMO, Hematology   •       –      –    2021-08-31 4 A $0.00 $0 D/D 542 542     -
   Huang Jane CMO, Hematology   •       –      –    2021-08-31 4 A $0.00 $0 D/D 7,163 305,824     -
   Oyler John Chief Executive Officer   •       •      –    2021-08-31 4 AS $299.74 $10,415,111 D/D (34,281) 0 -22%     
   Oyler John Chief Executive Officer   •       •      –    2021-08-31 4 AS $23.67 $1,817,756 D/D (76,800) 3,694,720 -22%     
   Oyler John Chief Executive Officer   •       •      –    2021-08-05 4 AS $331.64 $3,497,744 D/D (10,362) 0 -17%     
   Oyler John Chief Executive Officer   •       •      –    2021-08-05 4 AS $25.82 $880,302 D/D (34,100) 4,217,173 -17%     
   Oyler John Chief Executive Officer   •       •      –    2021-08-04 4 AS $340.40 $10,925,109 D/D (31,747) 0 -18%     
   Oyler John Chief Executive Officer   •       •      –    2021-08-04 4 AS $26.08 $1,280,479 D/D (49,100) 4,385,979 -18%     
   Oyler John Chief Executive Officer   •       •      –    2021-08-03 4 AS $323.74 $14,160,167 D/D (41,959) 0 -13%     
   Oyler John Chief Executive Officer   •       •      –    2021-08-03 4 AS $25.17 $1,041,881 D/D (41,400) 4,847,790 -13%     
   Oyler John Chief Executive Officer   •       •      –    2021-07-22 4 AS $308.86 $3,598,291 D/D (11,316) 0 7%     
   Oyler John Chief Executive Officer   •       •      –    2021-07-22 4 AS $23.71 $1,373,070 D/D (57,900) 5,434,657 7%     

  241 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed